KM

Kiran Mai Ganta

Active Director Director DIN 10120384
DIN 10120384 First appointment Apr 2023 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2023
Shareholding value •••• Premium profile

About Kiran Mai Ganta

Data last updated:

Kiran Mai Ganta is a Director at Sunrise Biosciences Private Limited (since 2023). The company operates in Pharma. Sunrise Biosciences Private Limited reported revenue of ₹12.28 Cr (FY 2024).

DIN 10120384
Primary Designation Director
Industry Pharma
First Appointment 18 Apr 2023
Oldest Company Age 3 yrs
Largest company Sunrise Biosciences Private Limited · ₹12.28 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Sunrise Biosciences Private Limited U46497TS2023PTC172036
Director18 Apr 20232023₹12.28 Cr (FY 2024)Active

Board colleagues of Kiran Mai Ganta

Directorship timeline

Open interactive timeline →
Sunrise Biosciences Private Limited
Premium access

Shareholding and investment profile for Kiran Mai Ganta

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kiran Mai Ganta

Kiran Mai Ganta currently holds 1 directorship: Sunrise Biosciences Private Limited (Director, since 18 Apr 2023, revenue ₹12.28 Cr (FY 2024)).

Kiran Mai Ganta was first appointed on 18 Apr 2023 as Director at Sunrise Biosciences Private Limited.

The current boards of Kiran Mai Ganta's companies include Kakumani Ravichandra (Sunrise Biosciences Private Limited), Siva Bhaskara Paturi Naren (Sunrise Biosciences Private Limited), Vanaja Sankula (Sunrise Biosciences Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available